Metabolites of the renal cytochrome P-450 -hydroxylase system have multiple effects on renal function. Infusion of 20-HETE into rat renal arteries resulted in natriuresis without affecting glomerular filtration rate or systemic blood pressure (34) . Inhibition of endogenous -hydroxylase activity by infusion of 17-octadecynoic acid into rat renal arteries also caused an increase in urine flow rate and sodium excretion (38) . These results are difficult to interpret, because these compounds are known to alter renal hemodynamics and affect transport in multiple nephron segments (1, 3, 13, 14, 16, 22, 27, 31) . 20-HETE constricts canine renal arcuate arteries (22) and rat renal arterioles (16) and increases renal vascular resistance (1) . The vascular effects of 20-HETE also play a role in autoregulation and tubuloglomerular feedback (36, 37) . 20 -HETE has been shown to modulate thick ascending limb sodium chloride transport (3, 13, 14, 31) . Cells from the thick ascending limb produce 20-HETE in culture, and production is stimulated by arginine vasopressin and calcitonin (13, 31) . 20-HETE inhibits transport in the thick ascending limb by blocking the Na-K-2Cl cotransporter (3, 14) . This inhibitory effect of 20-HETE on transport may be part of the signal transduction mechanism for the inhibition of transport by pharmacological doses of angiotensin II in this segment (4) .
The proximal tubule is a major site of renal cytochrome P-450 (12, 17, 22) . It has been estimated that the majority of 20-HETE produced by the kidney comes from the proximal tubule (20) . The effects of 20-HETE on proximal tubule transport remain unknown. The purpose of the present study was to directly examine the effect of 20-and 19(S)-HETE on volume transport in the in vitro microperfused rabbit proximal straight tubule (PST).
METHODS

Production of 20-HETE.
The production of 20-HETE from rabbit PST was measured using a modification of the method developed by Ito and Roman (18) . Briefly, PST from rabbit kidneys were dissected as described below and transferred to a test tube in Hanks' solution. The tubules were permeabilized with three freeze-thaw cycles using liquid nitrogen to snap freeze the tissue, followed by thawing in warm water. The tubules were then centrifuged at 4°C at 2,000 rpm for 5 min. The supernatant was aspirated, and the cells were resuspended in 1 ml of a buffer containing (in mM) 100 potassium phosphate (pH 7.4), 10 MgCl 2 , and 1 EDTA.
[ 3 H]arachidonic acid (4 µCi/ml; New England Nuclear, Bos-ton, MA), 1 mM NADPH, 10 mM isocitrate, and 0.4 U/ml isocitrate dehydrogenase (as an NADPH generating system) were then added to each tube. The tubes were then incubated at 37°C for 60 min with 100% O 2 blown over the tops. Three tubes were control with vehicle added, and three tubes were treated with 10 Ϫ5 M N-methylsulfonyl-12,12-dibromododec-11-enamide (DDMS). One tube contained the solutions without tubules to assess the rate of nonenzymatic conversion to 20-HETE. The reaction was terminated by adding 250 µl of 1 M formic acid. The lipids were then extracted by adding 2 ml of chloroform, vortexing, centrifuging at 2,000 rpm for 5 min, and then drying under nitrogen. The samples were then resuspended in 20 µl of ethanol and separated by HPLC using a C 18 column (150 ϫ 2.1 mm, 3 µm, ODS, Hypersil; ThermoQuest, San Jose, CA). The mobile phase was an acetonitrile: water:acetic acid (62.5:37.5:0.5) gradient to 100% acetonitrile in 20 min. Retention times for 20-HETE and arachidonic acid were determined by running standards under the same conditions. The fraction that came off at 7 min corresponded to 20-HETE, and the fraction at 19 min corresponded to arachidonic acid. Using this system, we found it was not possible to separate 19-from 20-HETE. The aqueous phase was saved to determine the protein concentration by bicinchoninic acid assay (BCA; Pierce Chemical, Rockford, IL).
Results were calculated by counting the 7-and 19-min fractions in a liquid scintillation counter. The counts were totaled, and the 20-HETE fraction was expressed as a fraction of the total, then factored for protein concentration. Results are expressed as the mean and standard error. Comparisons were made using unpaired t-test and significance was taken to be P Ͻ 0.05.
In vitro microperfusion. Superficial PST (S2 segment) from New Zealand White rabbits were perfused in vitro as previously described (11, 26) . Briefly, PST were dissected in cooled (4°C) modified Hanks' solution containing (in mM) 137 NaCl, 5 KCl, 0.8 MgSO 4 , 0.33 Na 2 HPO 4 , 0.44 KH 2 PO 4 , 1 MgCl 2 , 10 Tris · HCl, 0.25 CaCl 2 , 2 glutamine, and 2 L-lactate. This solution was bubbled with 100% O 2 and had a pH of 7.4. Tubules were then transferred to a 1.2-ml thermostatically controlled (37-38°C) bathing chamber and perfused with concentric glass pipettes. The perfusion solution simulated an ultrafiltrate of plasma and contained (in mM) 115 NaCl, 25 NaHCO 3 , 2.3 Na 2 HPO 4 , 10 sodium acetate, 1.8 CaCl 2 , 1 MgSO 4 , 5 KCl, 8.3 glucose, and 5 alanine. The bathing solution was similar, but contained 6 g/dl of albumin. All solutions were bubbled with 95% O 2 and 5% CO 2 at 37°C and had a pH of 7.4. The osmolalities of the perfusion and bathing solutions were adjusted to 295 mosmol/kgH 2 O by the addition of water or NaCl. The bathing solution was exchanged at a rate of 0.5 ml/min to keep the osmolality and pH constant.
The control period began after a 60-min incubation period. Volume absorption (J v ; in nl·min Ϫ1 ·mm Ϫ1 ) was measured as the difference between the perfusion and collection rates and normalized per millimeter of tubule length. The collection rate was determined by timed collections using a constantvolume pipette. Exhaustively dialyzed [methoxy-3 H]inulin (New England Nuclear) was added to the perfusate at a concentration of 50 µCi/ml so that the perfusion rate could be calculated. The tubule length (L) was measured using an eyepiece micrometer.
The transepithelial potential difference (PD, mV) was measured by using the perfusion pipette as the bridge into the tubular lumen. The recording and reference calomel half-cells were connected to the perfusion and bathing solutions via agarose bridges containing 3.6 M KCl/0.9 M KNO 3 . This arrangement avoids direct contact between the solution bathing the tubule and the KCl/KNO 3 agarose bridge. The recording and reference calomel half-cells were then connected to the high-and low-impedance sides, respectively, of an electrometer (model 602; Keithley Instruments, Cleveland, OH).
After five control measurements of J v and PD were made, the eicosanoid to be studied was added to the bathing solution. After 15 min of incubation, five measurements of J v and PD were made in the experimental period. Measurements of J v and PD in each period were averaged for that period.
Results are expressed as the means and standard error of all tubules in each series. Comparisons were made using paired t-test and significance was taken to be P Ͻ 0.05.
RESULTS
20-HETE production.
Rabbit proximal tubules were shown to metabolize arachidonic acid to 20-HETE. The control rate of conversion was 47.7 Ϯ 3.4 (0.18 Ϯ 0.02% · µg protein Ϫ1 · 60 min Ϫ1 ). DDMS significantly reduced this conversion rate to 17.7 Ϯ 1.8% · tube Ϫ1 ·60 min Ϫ1 (0.05 Ϯ 0.01% · µg protein Ϫ1 · 60 min Ϫ1 ; P Ͻ 0.01, n ϭ 3). The nonenzymatic conversion of arachidonic acid to 20-HETE was minimal (9.5% · tube Ϫ1 · 60 min Ϫ1 ) and was approximately the same as the DDMS-treated tubules. Thus rabbit PST are capable of producing 20-HETE and this is inhibited by DDMS.
In vitro microperfusion. The first series of experiments was designed to determine whether 20-HETE had a direct effect on PST J v . During the experimental period in these series, 20-HETE (10 Ϫ6 M or 10 Ϫ5 M) was added to the bathing solution. 20-HETE had no direct effect on J v [control, 0.50 Ϯ 0.10 vs. 10 Ϫ6 M 20-HETE, 0.50 Ϯ 0.12 nl · min Ϫ1 ·mm Ϫ1 ; n ϭ 4, P ϭ not significant (NS); and control, 0.45 Ϯ 0.12 vs. 10 Ϫ5 M 20-HETE, 0.46 Ϯ 0.14 nl · min Ϫ1 ·mm Ϫ1 ; n ϭ 6, P ϭ NS]. There was also no change in the PD (control, Ϫ1.2 Ϯ 0.3 vs. 10 Ϫ6 M 20-HETE, Ϫ1.2 Ϯ 0.2 mV; and control, Ϫ2.2 Ϯ 0.9 vs. 10 Ϫ5 M 20-HETE, Ϫ2.3 Ϯ 0.8 mV; P ϭ NS).
Since the major metabolite of arachidonic acid in rat proximal tubules is 20-HETE (24) and we had demonstrated that rabbit proximal tubules also produce 20-HETE, it is possible that the endogenous production rate is sufficiently high to mask the effect of any exogenously administered 20-HETE. To evaluate this possibility, endogenous production of 20-HETE was blocked using DDMS, an -hydroxylase inhibitor with little effect on epoxygenase activity (1). Figure 1 Thus the effect to stimulate transport must be a direct effect and not due to any effect on 20-HETE production.
DISCUSSION
The present study examined the direct effects of -hydroxylase products of arachidonic acid on proximal tubule volume transport. We demonstrated that rabbit PST are capable of converting arachidonic acid to 20-HETE. This conversion is inhibited by DDMS. Addition of exogenous 20-HETE, the major product of -hydroxylase, had no direct effect on PST volume transport. Inhibition of 20-HETE production with the -hydroxylase inhibitor, DDMS, stimulated volume transport in the PST. This implies that the high endogenous production of 20-HETE may play a role in suppressing transport rates. In the presence of DDMS, exogenous 20-HETE had a significant effect to inhibit transport. The -1 product of arachidonic acid, 19(S)-HETE, stimulated transport regardless of whether DDMS was present. This indicates that 19(S)-HETE directly stimulates transport without having to affect 20-HETE metabolism. Thus the -hydroxylase products of arachidonic acid play a role in the control of volume transport in the PST.
Although the effects of these compounds on proximal tubule transport have not been previously examined, their effects on Na-K-ATPase activity have been studied (15, 25, 27) . 20-HETE inhibits Na-K-ATPase in this segment and is thought to play a role in the effect of parathyroid hormone and dopamine to inhibit transport in this segment (25, 27) . 19(S)-HETE, the major -1 product of -hydroxylase, has been shown to stimulate rat renal Na-K-ATPase activity (15) . Although Na-K-ATPase activity in the proximal tubule is a determinant of solute and volume transport, effects on the Na-K-ATPase do not always correlate with effects on J v . Dopamine, for example, has been shown to inhibit proximal convoluted tubule Na-K-ATPase but has no direct effect on transport in this segment (5, 9, 10) . Thus the relationship between regulating Na-KATPase activity and J v rates is complex and indicates the importance of directly examining proximal tubule transport. Changes in J v rates in the present study were not associated with changes in PD. This is in contrast to previous studies in which increases in J v rate correlated with increases in the PD (6) and decreases in transport correlated with decreases in the PD (8, 29) . This suggests that the mechanism by which the J v rates were increased may be due to changes in electroneutral transport and not due to direct changes in the Na-KATPase (7).
The proximal tubule reabsorbs between 60 and 70% of the glomerular ultrafiltrate (30) . Thus small changes in the volume absorption rate in this nephron segment lead to large changes in overall fluid balance of the organism. Inhibiting -hydroxylase activity in this nephron segment led to an increase in transport by 16-28%, which could then cause volume overload and hypertension. This indicates that renal P-450 -hydroxylase may be involved in extracellular fluid volume and blood pressure regulation.
The role of the renal P-450 system in the development of hypertension has been complex. The Dahl salt-sensitive rat (SS) is a model of hypertension that has been extensively studied, and renal cytochrome P-450 abnormalities may be involved in the development of hypertension in this model (28) . In vivo perfusion studies indicate that the SS rats reabsorb more sodium in the loop of Henle than the salt-resistant (SR) or Lewis rats, indicating that tubular transport is higher in these animals (33, 35) . Addition of 20-HETE to the perfusate in these studies reduced the chloride transport rates (35) . More recently, thick ascending limbs from SS animals were shown to have higher transport rates that were reduced with 20-HETE than SR animals (19) . Thus 20-HETE is a key factor in regulating sodium and chloride transport and volume regulation.
The above in vivo and in vitro studies examined the role of 20-HETE on thick ascending limb of Henle transport (19, 33, 35) . Since the highest concentration of renal P-450 is in the proximal tubule, the effect of 20-HETE production on transport in this segment was important to examine (12) . The present study directly demonstrates that endogenous production of 20-HETE exerts an effect to inhibit transport in the PST. When the endogenous production was blocked, exogenous administration of 20-HETE inhibited transport. These findings are consistent with the above studies linking a low production rate of 20-HETE with the development of hypertension.
The present study demonstrated direct effects of 20-and 19(S)-HETE on proximal tubule transport. The addition of 20-HETE inhibited proximal tubule transport only when endogenous production was inhibited with DDMS. 19(S)-HETE was capable of stimulating volume transport in the absence and presence of DDMS. Thus the -hydroxylase products of arachidonic acid play a role in regulating proximal tubule transport.
